论文部分内容阅读
目的分析我国医药制造业技术引进和消化吸收情况,为我国医药制造业政策制订提供参考。方法根据《中国高技术产业统计年鉴》(2010-2013)提供的数据,采用对比分析方法 ,从不同登记注册类型、不同子行业、不同规模和不同地区4个角度对我国医药制造业企业的技术引进经费支出和消化吸收经费支出进行整理和分析。结果 2009年至2012年,我国医药制造业中,无论登记注册类型、子行业、地区及规模,企业的消化吸收经费支出大多不足技术引进经费的3倍,低于发达国家经验值,且均不存在明显的增长趋势。结论我国医药制造业企业应增加引进技术经费投入,加强对引进技术的后续研究,协调引进技术经费投入与消化吸收经费投入之间的关系,优化引进技术的组成,培养更多高水平的医药人才。
Objective To analyze the technology import and digestion and absorption in China’s pharmaceutical manufacturing industry and provide reference for the formulation of the pharmaceutical manufacturing policy in our country. Methods Based on the data provided by the China Statistical Yearbook on High-tech Industries (2010-2013), a comparative analysis method was used to analyze the technology of Chinese pharmaceutical manufacturing enterprises from four different registration types, different sub-industries, different scales and different regions The introduction of expenditures and the digestion and absorption of funds for sorting and analysis. Results From 2009 to 2012, regardless of the types of registrations, sub-industries, regions and scale, the majority of enterprises in the pharmaceutical manufacturing industry in China lacked digestion and absorption expenditures, which were less than 3 times the cost of technology imports and lower than those of developed countries, There is a clear trend of growth. Conclusion The pharmaceutical manufacturing enterprises in our country should increase the investment of introducing technical funds, strengthen the follow-up research on the imported technologies, coordinate the relationship between the introduction of technical funds and the input of digesting and absorbing funds, optimize the composition of the imported technologies and cultivate more high-level medical talents .